Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/27302
RECOMBINANT PROTEINS OF HPV16 CAPSID EXPRESSED IN 293-F CELLS CULTURED IN SUSPENSION AND SERUM FREE MEDIUM FOR VACCINE DEVELOPMENT
Author
Affilliation
Instituto Butantan. Laboratório de Genética. Butantã, SP, Brasil.
Instituto Butantan. Laboratório de Genética. Butantã, SP, Brasil.
Instituto Butantan. Laboratório de Genética. Butantã, SP, Brasil.
Institute for Medical Research. Department of Biology and Cancer Research. EUA.
Johns Hopkins University. Department of Pathology. Baltimore, MD, USA.
German Cancer Research Center. Inflammation and Cancer Program. Infection. Tumor virus-specific Vaccination Strategies. Im Neuenheimer Feld, Heidelberg, Germany.
Instituto Butantan. Laboratório de Genética. Butantã, SP, Brasil.
Instituto Butantan. Laboratório de Genética. Butantã, SP, Brasil.
Instituto Butantan. Laboratório de Genética. Butantã, SP, Brasil.
Institute for Medical Research. Department of Biology and Cancer Research. EUA.
Johns Hopkins University. Department of Pathology. Baltimore, MD, USA.
German Cancer Research Center. Inflammation and Cancer Program. Infection. Tumor virus-specific Vaccination Strategies. Im Neuenheimer Feld, Heidelberg, Germany.
Instituto Butantan. Laboratório de Genética. Butantã, SP, Brasil.
Share